CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 77939 | EN ISO 10993-4:2017/A1:2025 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood - Amendment 1 (ISO 10993-4:2017/Amd 1:2025, Corrected version 2025-04) | Standarts spēkā |
| 32000 | EN ISO 10993-14:2009 | Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001) | Standarts spēkā |
| 67187 | EN ISO 10993-10:2023 | Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO/DIS 10993-10:2020) | Standarts spēkā |
| 64034 | LVS EN ISO 10993-7:2009/A1:2022 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Amendment 1: Applicability of allowable limits for neonates and infants (ISO 10993-7:2008/Amd 1:2019) | Standarts spēkā |
| 27051 | EN ISO 10993-13:2010 | Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO/DIS 10993-13:2008) | Standarts spēkā |
| 67095 | EN ISO 10993-12:2021 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO/DIS 10993-12:2019) | Standarts spēkā |
| 33857 | EN ISO 10993-7:2008/AC:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Technical Corrigendum 1 (ISO 10993-7:2008/Cor 1:2009) | Standarts spēkā |
| 9493 | EN ISO 10993-7:2008 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Standarts spēkā |
| 25795 | EN ISO 22442-3:2007 | Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007) | Standarts spēkā |
| 74131 | LVS EN ISO 10993-18:2020/A1:2023 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/Amd 1:2022) | Standarts spēkā |
Displaying 11-20 of 194 results.
